Evidence map›Paper›PMID 25293959›Full record

ArticleBMC medical genetics2014

Replication and exploratory analysis of 24 candidate risk polymorphisms for neural tube defects.

Faith Pangilinan, Anne M Molloy, James L Mills, James F Troendle, Anne Parle-McDermott, Denise M Kay, Marilyn L Browne, Emily C McGrath, Hatice Ozel Abaan, Marie Sutton and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Should vitamin BAnnals of the New York Academy of Sciences · 2018
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 2 countries.

Faith PangilinanMolecular Pathogenesis Section, Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Room 5306, 50 South Drive, Bethesda, MD, 20892-8004, USA. faith@mail.nih.gov.
Anne M MolloyDepartment of Clinical Medicine, Trinity College Dublin, Dublin, Ireland. amolloy@tcd.ie.
James L MillsDivision of Epidemiology, Statistics and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. millsj@exchange.nih.gov.
James F TroendleOffice of Biostatistics Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. troendlj@nhlbi.nih.gov.
Anne Parle-McDermottSchool of Biotechnology, Dublin City University, Dublin, Ireland. anne.parle-mcdermott@dcu.ie.
Denise M KayNew York State Department of Health, Division of Genetics, Wadsworth Center, Albany, NY, 12201, USA. dmk11@health.state.ny.us.
Marilyn L BrowneNew York State Department of Health, Congenital Malformations Registry, Troy, NY, 12180, USA. mlb10@health.state.ny.us.
Emily C McGrathNew York State Department of Health, Division of Genetics, Wadsworth Center, Albany, NY, 12201, USA. exc14@health.state.ny.us.
Hatice Ozel AbaanMolecular Pathogenesis Section, Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Room 5306, 50 South Drive, Bethesda, MD, 20892-8004, USA. habaan@mail.nih.gov.
Marie SuttonEvidence Centre, Health Research Board, Dublin, Ireland. msutton@hrb.ie.
Peadar N KirkeChild Health Epidemiology Unit, Health Research Board, Dublin, Ireland. pkirke@live.ie.
Michele CagganaNew York State Department of Health, Division of Genetics, Wadsworth Center, Albany, NY, 12201, USA. caggana@wadsworth.org.
Barry ShaneDepartment of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, 94720-3104, USA. bandie@berkeley.edu.
John M ScottSchool of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland. lbrody@mail.nih.gov.
Lawrence C BrodyMolecular Pathogenesis Section, Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Room 5306, 50 South Drive, Bethesda, MD, 20892-8004, USA. lbrody@mail.nih.gov.
National Institutes of Health · USHealth Research Board · IENational Human Genome Research Institute · USNew York State Department of Health · USTrinity College Dublin · IEDublin City University · IEUniversity at Albany, State University of New York · USUniversity of California, Berkeley · USWadsworth Center · US

Funding

The contribution folate and vitamin B12 genes to disease.ZIAHG000167 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BRODY, LAWRENCE C · 2009 to 2025
$17.6M
NICHD Health Research Board Of Ireland Neural Tube Defects StudyZIAHD002502 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MILLS, JAMES · 2009 to 2022
$2.9M
Intramural NIH HHSNIDDK NIH HHS N01-DK-7-3431
6 · The paper itself

Abstract

backgroundNeural tube defects (NTDs), which are among the most common congenital malformations, are influenced by environmental and genetic factors. Low maternal folate is the strongest known contributing factor, making variants in genes in the folate metabolic pathway attractive candidates for NTD risk. Multiple studies have identified nominally significant allelic associations with NTDs. We tested whether associations detected in a large Irish cohort could be replicated in an independent population.

methodsReplication tests of 24 nominally significant NTD associations were performed in racially/ethnically matched populations. Family-based tests of fifteen nominally significant single nucleotide polymorphisms (SNPs) were repeated in a cohort of NTD trios (530 cases and their parents) from the United Kingdom, and case-control tests of nine nominally significant SNPs were repeated in a cohort (190 cases, 941 controls) from New York State (NYS). Secondary hypotheses involved evaluating the latter set of nine SNPs for NTD association using alternate case-control models and NTD groupings in white, African American and Hispanic cohorts from NYS.

resultsOf the 24 SNPs tested for replication, ADA rs452159 and MTR rs10925260 were significantly associated with isolated NTDs. Of the secondary tests performed, ARID1A rs11247593 was associated with NTDs in whites, and ALDH1A2 rs7169289 was associated with isolated NTDs in African Americans.

conclusionsWe report a number of associations between SNP genotypes and neural tube defects. These associations were nominally significant before correction for multiple hypothesis testing. These corrections are highly conservative for association studies of untested hypotheses, and may be too conservative for replication studies. We therefore believe the true effect of these four nominally significant SNPs on NTD risk will be more definitively determined by further study in other populations, and eventual meta-analysis.

Indexed as

5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseAdenosine DeaminaseAldehyde Dehydrogenase 1 FamilyAsian PeopleBlack or African AmericanDNA-Binding ProteinsGenetic Association StudiesGenetic Predisposition to DiseaseHumansNeural Tube DefectsNew YorkNuclear ProteinsPolymorphism, Single NucleotideRetinal DehydrogenaseTranscription FactorsUnited Kingdom5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseADA protein, humanAdenosine DeaminaseAldehyde Dehydrogenase 1 FamilyALDH1A2 protein, humanARID1A protein, humanDNA-Binding ProteinsMTR protein, humanNuclear ProteinsRetinal DehydrogenaseTranscription Factors

Identifiers

PMID25293959
PMCPMC4411759
OpenAlexW2022088385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.